Shoba L. Subramanian, MD works in the field of Endocrinology. He received awards:"CMS Meaningful Use Stage 1 Certification". Shoba Subramanian is also a published MD. He has 6 paper published. The most recent paper is: One year of sitagliptin treatment protects against islet amyloid-associated -cell loss and does not induce pancreatitis or pancreatic neoplasia in mice. Shoba L. Subramanian accepts Medicare.
University of Washington
Stanford University
University of Toronto Faculty of Medicine
Swedish Medical Center-Cherry Hill Campus| NPI NUMBER | 1942493341 | |
| NPPES Provider LastName | SUBRAMANIAN | |
| NPPES Provider FirstName | SHOBA | |
| NPPES Provider ZIPCode | 940402833 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1127.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
| National Provider Identifier [NPI] | 1942493341 |
| Last Name Of The Provider | SUBRAMANIAN |
| First Name Of The Provider | SHOBA |
| View All |
|
Dr. Rachael White, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Samira Kirmiz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Preethi C. Sridhar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lynn J. Bennion, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Linda Membreno, MD
This Doctor is OpenDoctor Recommended.
|